deferiprone has been researched along with Emesis in 1 studies
Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thrombocytopenia is one of the major side effects in young thalassaemics and necessitates frequent close monitoring of blood counts but its resolution after discontinuation and absence of clinical evidence of bleeding does not preclude its use." | 2.71 | Safety of oral iron chelator deferiprone in young thalassaemics. ( Chandra, J; Naithani, R; Sharma, S, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Naithani, R | 1 |
| Chandra, J | 1 |
| Sharma, S | 1 |
1 trial available for deferiprone and Emesis
| Article | Year |
|---|---|
Safety of oral iron chelator deferiprone in young thalassaemics.
Topics: Blood Cell Count; Child; Child, Preschool; Deferiprone; Female; Follow-Up Studies; Humans; Iron Chel | 2005 |